Page last updated: 2024-08-21

pivalylbenzhydrazine and iproniazid

pivalylbenzhydrazine has been researched along with iproniazid in 3 studies

*Iproniazid: An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. [MeSH]

*Iproniazid: An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DIGHIERO, J; HAZAN, J; RUDOLF, J1
ABRAMS, WB; BECKER, MC; KILLOUGH, JH; LEWIS, DW1
CALATAYUD, JB; ORVIS, HH; PRANDONI, AG1

Other Studies

3 other study(ies) available for pivalylbenzhydrazine and iproniazid

ArticleYear
[Clinical study of a derivative of iproniazid, tersavid, in the treatment of angina pectoris].
    Prensa medica argentina, 1960, Mar-25, Volume: 47

    Topics: Angina Pectoris; Biomedical Research; Iproniazid; Propionates

1960
Amine oxidase inhibitors in the treatment of angina pectoris; preliminary report on marplan and tersavid.
    The American journal of cardiology, 1960, Volume: 5

    Topics: Amines; Angina Pectoris; Humans; Iproniazid; Oxidoreductases; Propionates

1960
Double-blind evaluation of an iproniazid analog (Ro 4-1634) in the treatment of angina pectoris.
    Journal of the American Geriatrics Society, 1961, Volume: 9

    Topics: Angina Pectoris; Double-Blind Method; Iproniazid; Propionates

1961